BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38627705)

  • 1. No side effects on rabbit retina or vitreous microenvironment by nd:YAG laser vitreolysis.
    Lin T; Zhang M; Wu B; An Y; Pazo EE; Li R; Shen L
    BMC Ophthalmol; 2024 Apr; 24(1):171. PubMed ID: 38627705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute retinal detachment after Nd:YAG treatment for vitreous floaters and postertior capsule opacification: a case report.
    Liu X; Wang Q; Zhao J
    BMC Ophthalmol; 2020 Apr; 20(1):157. PubMed ID: 32306922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of YAG laser vitreolysis for intraocular tissues: analysis of postoperative complications.
    Liu J; Wang H; Gu W; Zhao T; Fan W; Peng S
    Int Ophthalmol; 2023 Dec; 43(12):4585-4593. PubMed ID: 37665493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters.
    Luo J; An X; Kuang Y
    J Int Med Res; 2018 Nov; 46(11):4465-4471. PubMed ID: 30200800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory open-angle glaucoma after neodymium-yttrium-aluminum-garnet laser lysis of vitreous floaters.
    Cowan LA; Khine KT; Chopra V; Fazio DT; Francis BA
    Am J Ophthalmol; 2015 Jan; 159(1):138-43. PubMed ID: 25308785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters.
    Kokavec J; Wu Z; Sherwin JC; Ang AJ; Ang GS
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011676. PubMed ID: 28570745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis.
    Nguyen JH; Nguyen-Cuu J; Yu F; Yee KM; Mamou J; Silverman RH; Ketterling J; Sebag J
    Ophthalmology; 2019 Nov; 126(11):1517-1526. PubMed ID: 31471088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of early YAG laser vitreolysis for symptomatic vitreous floaters: the study protocol for a randomized clinical trial.
    Hangshuai Z; Yanhua J; Yao Z; Guangjin Z; Hongyan W; Fanlian C
    Trials; 2024 Jan; 25(1):48. PubMed ID: 38218919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters.
    Delaney YM; Oyinloye A; Benjamin L
    Eye (Lond); 2002 Jan; 16(1):21-6. PubMed ID: 11913884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cataracts induced by neodymium-yttrium-aluminium-garnet laser lysis of vitreous floaters.
    Koo EH; Haddock LJ; Bhardwaj N; Fortun JA
    Br J Ophthalmol; 2017 Jun; 101(6):709-711. PubMed ID: 27574177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LASER VITREOLYSIS IN PATIENTS WITH SYMPTOMATIC VITREOUS FLOATERS.
    Janeková A; Veith M; Fillová D; Janek M
    Cesk Slov Oftalmol; 2022; 78(6):288-295. PubMed ID: 36543595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of YAG-laser vitreolysis effectiveness based on quantitative characterization of vitreous floaters].
    Shaimova VA; Shaimov TB; Shaimov RB; Galin AY; Goloshchapova ZA; Ryzhkov PK; Fomin AV
    Vestn Oftalmol; 2018; 134(1):56-62. PubMed ID: 29543200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal Complications after Yttrium-Aluminum-Garnet Laser Vitreolysis for Vitreous Floaters.
    Shields RA; Cheng OT; Ruby AJ; Williams GA; Wolfe JD
    Ophthalmic Surg Lasers Imaging Retina; 2021 Nov; 52(11):610-613. PubMed ID: 34766848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.
    Shah CP; Heier JS
    JAMA Ophthalmol; 2017 Sep; 135(9):918-923. PubMed ID: 28727887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nd:YAG Laser Vitreolysis for Symptomatic Vitreous Floaters: Application of Infrared Fundus Photography in Assessing the Treatment Efficacy.
    Sun X; Tian J; Wang J; Zhang J; Wang Y; Yuan G
    J Ophthalmol; 2019; 2019():8956952. PubMed ID: 30809388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous floaters: A randomized controlled trial.
    Ludwig GD; Gemelli H; Nunes GM; Serracarbassa PD; Zanotele M
    Eur J Ophthalmol; 2021 May; 31(3):909-914. PubMed ID: 33148023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous humor rheology after Nd:YAG laser photo disruption.
    Abdelkawi SA; Abdel-Salam AM; Ghoniem DF; Ghaly SK
    Cell Biochem Biophys; 2014 Mar; 68(2):267-74. PubMed ID: 23797611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of laser vitreolysis for vitreous floaters in posterior vitreous detachment.
    Goh WN; Mustapha M; Zakaria SZS; Bastion MC
    Indian J Ophthalmol; 2022 Aug; 70(8):3026-3032. PubMed ID: 35918966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological Evaluation of Retina after Photo Disruption for Vitreous Humor by Q-Switched Neodymium-Doped Yttrium Aluminium Garnet (Nd:YAG) Laser.
    Kameel Ghaly S; Foad Ghoneim D; Abdelkawi Ahmed S; Medhat Abdel-Salam A
    J Lasers Med Sci; 2013; 4(4):190-8. PubMed ID: 25606329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Follow-Up of Efficacy and Safety of YAG Vitreolysis for Symptomatic Weiss Ring Floaters.
    Shah CP; Heier JS
    Ophthalmic Surg Lasers Imaging Retina; 2020 Feb; 51(2):85-88. PubMed ID: 32084280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.